Asosiy kontentga oʻtish
Sharh maqola

Therapeutic approaches in the treatment of gout

Michael H. PillingerThe Division of Rheumatology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, United StatesBrian F. MandellRheumatic and Immunologic Diseases, The Cleveland Clinic, Cleveland, OH, United States
2020en
ABI

Annotatsiya

Gout is a disease in which the metabolic condition hyperuricemia leads to the formation of monosodium urate crystals, which provoke acute and chronic inflammatory responses through activation of the innate immune system. Recent advances in our knowledge of gout pathogenesis have emphasized the role of the kidneys in urate handling, the evolutionary loss of uricase as a necessary precondition for hyperuricemia, and the central role of IL-1ß in the pathogenesis of gouty inflammation. These, and other advances, have shaped our current strategies for managing gout. Here, we review the most current, evidence-based gout management approaches, including treating acute flares, addressing gout through the long-term regulation of serum urate, and prophylaxis against gouty flares during urate lowering.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

2 ta iqtibos0 ta foydalanilgan manba